Compare the six-month outcome of three different ultrasound-guided treatments for de Quervain's disease

Ultrasound-guided percutaneous injection to treat de Quervain's disease using three different techniques: a randomized controlled trial.

Article specifications

This clinical trial was published in 2015 in Journal of Eur Radiol. (IF 2014:4.014) by Italian specialists. The aim of this study was to compare the six-month outcome of three different ultrasound-guided treatments for de Quervain's disease (DQD). Patients were randomized into three groups of 25 patients each treated under ultrasound guidance: Group A (1 ml methylprednisolone acetate; mean baseline thickness = 1.6 mm; mean baseline VAS = 6; mean baseline quickDASH = 55); Group B (1 ml methylprednisolone acetate +15-day delayed 2 ml saline 0.9 %; 1.4; 6; 56); Group C (1 ml methylprednisolone acetate +15-day delayed 2 ml low molecular weight hyaluronic acid; 1.7; 6; 55).

 

Result

Addition of hyaluronic acid to ultrasound-guided injections of steroids to treat DQD seems to improve the outcome and to reduce the recurrence rate.